Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

54.6K
Overview
54.6K
Vaccine Production01:23

Vaccine Production

85
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
85
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

55
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
55
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cross-reactivity00:42

Cross-reactivity

34.0K
Overview
34.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newborns with sickle cell trait have distinct peripheral blood molecular signatures across the first week of life.

Blood. Red cells & iron·2026
Same author

Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trial.

The Lancet. Infectious diseases·2026
Same author

A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TB.

Clinical proteomics·2026
Same author

Population-specific heterogeneity in ontogeny of the broadly-conserved blood transcriptional program during the first week of life.

Nature communications·2026
Same author

Research priorities for improved pandemic and epidemic intelligence.

The Lancet. Global health·2026
Same author

Increase in imported mupirocin-resistant <i>Staphylococcus aureus</i> from the tropics and subtropics: trends in Berlin from 2018 to 2025.

New microbes and new infections·2026

Related Experiment Video

Updated: Apr 12, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K

Biological challenges to effective vaccines in the developing world.

Nicholas C Grassly1, Gagandeep Kang2, Beate Kampmann3

  • 1Department of Infectious Disease Epidemiology, Imperial College London, St Mary's Hospital, Norfolk Place, London W2 1PG, UK The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu 632004, India n.grassly@imperial.ac.uk.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|May 13, 2015
PubMed
Summary

Vaccine effectiveness varies across different settings due to biological challenges. This issue explores reasons for underperformance and strategies to enhance vaccine immunogenicity and efficacy in diverse populations.

Keywords:
immunizationimmunologyinfectious diseasevaccinevaccinology

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Related Experiment Videos

Last Updated: Apr 12, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Area of Science:

  • Immunology
  • Vaccinology
  • Global Health

Background:

  • Vaccine performance is not uniform across all populations and environments.
  • Understanding biological factors influencing vaccine response is crucial for public health.

Purpose of the Study:

  • To review vaccine performance in challenging environments.
  • To summarize current knowledge on vaccine underperformance.
  • To identify approaches for improving vaccine immunogenicity and efficacy.

Main Methods:

  • Literature review of vaccine performance data.
  • Synthesis of current research on biological challenges to vaccines.
  • Discussion of strategies to address response heterogeneity.

Main Results:

  • Vaccine efficacy can be significantly impacted by biological factors in specific settings.
  • Heterogeneity in immune responses contributes to variable vaccine outcomes.
  • Several approaches are proposed to improve vaccine effectiveness.

Conclusions:

  • Addressing biological challenges is key to optimizing vaccine performance globally.
  • Further research is needed to understand and overcome vaccine response variability.
  • Improving vaccine immunogenicity and efficacy requires tailored strategies for diverse populations.